Analysis of Disease Activity Metrics in a Methotrexate Withdrawal Study among Patients with Rheumatoid Arthritis Treated with Tofacitinib plus Methotrexate

被引：0
|
作者：
Roy Fleischmann
Boulos Haraoui
Maya H. Buch
David Gold
Gosford Sawyerr
Harry Shi
Annette Diehl
Kristen Lee
机构：
[1] Metroplex Clinical Research Center and University of Texas Southwestern Medical Center,Centre for Musculoskeletal Research
[2] Institut de Rhumatologie de Montréal,undefined
[3] University of Manchester,undefined
[4] and NIHR Manchester Biomedical Research Centre,undefined
[5] Pfizer Canada ULC,undefined
[6] Pfizer Inc,undefined
[7] Pfizer Inc,undefined
来源：
Rheumatology and Therapy | 2023年 / 10卷
关键词：
Rheumatoid arthritis; Inflammation; Methotrexate; Therapeutics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：375 / 386
页数：11
相关论文
共 50 条
  • [41] Assessment of Lipid Changes in Patients with Early Rheumatoid Arthritis Treated with Tofacitinib or Methotrexate over 24 Months
    Charles-Schoeman, C.
    Dikranian, A.
    Taylor, J.
    Wilkinson, B.
    Jones, T.
    Kwok, K.
    Nduaka, C.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S209 - S209
  • [42] Investigation of candidate polymorphisms and disease activity in rheumatoid arthritis patients on methotrexate
    Lee, Yvonne C.
    Cui, Jing
    Costenbader, Karen H.
    Shadick, Nancy A.
    Weinblatt, Michael E.
    Karlson, Elizabeth W.
    RHEUMATOLOGY, 2009, 48 (06) : 613 - 617
  • [43] BIOMARKER CHANGES FOR PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING TOFACITINIB WITH METHOTREXATE OR GLUCOCORTICOIDS VS TOFACITINIB MONOTHERAPY
    Lee, Julie
    Chen, Xing
    Zhang, Weidong
    Martin, David
    Hyde, Craig
    Hirose, Tomohiro
    Shah, Shweta
    Fitz, Lori
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1500 - 1500
  • [44] Phase II Study of Tofacitinib (CP-690,550) Combined With Methotrexate in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate
    Tanaka, Yoshiya
    Suzuki, Makoto
    Nakamura, Hiroyuki
    Toyoizumi, Shigeyuki
    Zwillich, Samuel H.
    ARTHRITIS CARE & RESEARCH, 2011, 63 (08) : 1150 - 1158
  • [45] The relation of disease activity and methotrexate with the risk of cardiovascular disease in patients with rheumatoid arthritis
    Welsing, PMJ
    Kievit, W
    Fransen, J
    Van Riel, PLCM
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 90 - 90
  • [46] A latent variable approach for modeling categorical endpoints among patients with rheumatoid arthritis treated with golimumab plus methotrexate
    Hu, Chuanpu
    Xu, Zhenhua
    Rahman, Mahboob U.
    Davis, Hugh M.
    Zhou, Honghui
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2010, 37 (04) : 309 - 321
  • [47] A latent variable approach for modeling categorical endpoints among patients with rheumatoid arthritis treated with golimumab plus methotrexate
    Chuanpu Hu
    Zhenhua Xu
    Mahboob U. Rahman
    Hugh M. Davis
    Honghui Zhou
    Journal of Pharmacokinetics and Pharmacodynamics, 2010, 37 : 309 - 321
  • [48] Biomarker Changes for Patients with Rheumatoid Arthritis Receiving Tofacitinib with Methotrexate or Glucocorticoids vs Tofacitinib Monotherapy
    Lee, Julie
    Chen, Xing
    Zhang, Weidong
    Martin, David
    Hyde, Craig
    Hirose, Tomohiro
    Shah, Shweta
    Fitz, Lori
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [49] Time to Discontinuation of Tofacitinib in Rheumatoid Arthritis Patients with and Without Methotrexate: Results from a Rheumatoid Arthritis Cohort
    Movahedi, Mohammad
    Cesta, Angela
    Li, Xiuying
    Keystone, Edward
    Bombardier, Claire
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [50] Tofacitinib Monotherapy Versus Methotrexate in Methotrexate-Naive Patients with Rheumatoid Arthritis: Radiographic, Clinical and Functional Comparison
    Fleischmann, R. M.
    Lee, E. B.
    Hall, S.
    Wilkinson, B. E.
    Bradley, John D.
    Gruben, D.
    Koncz, T.
    Krishnaswami, S.
    Wallenstein, G.
    Zwillich, S. H.
    van Vollenhoven, R. F.
    ARTHRITIS AND RHEUMATISM, 2013, 65 (12): : 3323 - 3323
12345